NeuroMetrix, Inc.
NURO · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8 | $8 | $7 | $7 |
| - Cash | $1 | $1 | $2 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $7 | $7 | $6 | $6 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -0.8% | -23.6% | -29.7% | – |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | 61.6% | 53.1% | 64% | 47.3% |
| EBITDA | -$2 | -$2 | -$2 | -$3 |
| % Margin | -295.8% | -286.4% | -225.8% | -295.3% |
| Net Income | -$2 | -$2 | -$1 | -$3 |
| % Margin | -305.5% | -256.8% | -193.5% | -277% |
| EPS Diluted | -0.87 | -0.75 | -0.74 | -1.67 |
| % Growth | -16% | -1.4% | 55.7% | – |
| Operating Cash Flow | -$2 | -$2 | -$1 | -$2 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$1 | -$2 |